Bliss JM - Search Results

1

Long-term assessment of quality of life in the Intergroup Exemestane Study: 5 years post-randomisation.

Fallowfield LJ, Kilburn LS, Langridge C, Snowdon CF, Bliss JM, Coombes RC; IES Trial Steering Committee. Fallowfield LJ, et al. Among authors: bliss jm. Br J Cancer. 2012 Mar 13;106(6):1062-7. doi: 10.1038/bjc.2012.43. Epub 2012 Feb 21. Br J Cancer. 2012. PMID: 22353807 Free PMC article. Clinical Trial.

2

Mitozantrone and methotrexate chemotherapy with and without mitomycin C in the treatment of advanced breast cancer: a randomised clinical trial.

Stein RC, Bower M, Law M, Bliss JM, Barton C, Gazet JC, Ford HT, Coombes RC. Stein RC, et al. Among authors: bliss jm. Eur J Cancer. 1992;28A(12):1963-5. doi: 10.1016/0959-8049(92)90237-v. Eur J Cancer. 1992. PMID: 1419290 Clinical Trial.

3

A method for assessing the quality of life of cancer patients: replication of the factor structure.

Bliss JM, Selby PJ, Robertson B, Powles TJ. Bliss JM, et al. Br J Cancer. 1992 Jun;65(6):961-6. doi: 10.1038/bjc.1992.201. Br J Cancer. 1992. PMID: 1616871 Free PMC article.

4

Chemotherapy for malignant melanoma: combinations and high doses produce more responses without survival benefit.

Lakhani S, Selby P, Bliss JM, Perren TJ, Gore ME, McElwain TJ. Lakhani S, et al. Among authors: bliss jm. Br J Cancer. 1990 Feb;61(2):330-4. doi: 10.1038/bjc.1990.65. Br J Cancer. 1990. PMID: 1690022 Free PMC article.

5

4-Hydroxyandrostenedione in the prophylaxis of N-methyl-N-nitrosourea induced mammary tumourigenesis.

Coombes RC, Wilkinson JR, Bliss JM, Shah P, Easton DF, Dowsett M. Coombes RC, et al. Among authors: bliss jm. Br J Cancer. 1991 Aug;64(2):247-50. doi: 10.1038/bjc.1991.285. Br J Cancer. 1991. PMID: 1892751 Free PMC article.

6

Effect of human recombinant tumour necrosis factor and rat gamma interferon on nitrosomethylurea-induced mammary tumours.

Shah P, van der Meide PH, Borman T, Schroeder N, Bliss JM, Coombes RC. Shah P, et al. Among authors: bliss jm. Br J Cancer. 1989 Feb;59(2):206-9. doi: 10.1038/bjc.1989.42. Br J Cancer. 1989. PMID: 2495016 Free PMC article.

7

Design and rationale of a randomised comparison of cyclophosphamide, methotrexate and fluorouracil vs fluorouracil, epirubicin and cyclophosphamide in node-positive premenopausal women with operable breast cancer. A trial of the International Collaborative Cancer Group (ICCG).

Wils J, Coombes RC, Marty M, Bliss J, Woods E. Wils J, et al. Drugs. 1993;45 Suppl 2:46-50; discussion 49-50. doi: 10.2165/00003495-199300452-00008. Drugs. 1993. PMID: 7693422 Clinical Trial.

8

Idoxifene is equipotent to tamoxifen in inhibiting mammary carcinogenesis but forms lower levels of hepatic DNA adducts.

Pace P, Jarman M, Phillips D, Hewer A, Bliss J, Coombes RC. Pace P, et al. Br J Cancer. 1997;76(6):700-4. doi: 10.1038/bjc.1997.449. Br J Cancer. 1997. PMID: 9310233 Free PMC article.

9

Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study.

Mansi JL, Gogas H, Bliss JM, Gazet JC, Berger U, Coombes RC. Mansi JL, et al. Among authors: bliss jm. Lancet. 1999 Jul 17;354(9174):197-202. doi: 10.1016/s0140-6736(98)10175-7. Lancet. 1999. PMID: 10421301

10

Duration of adjuvant chemotherapy; anthracyclines, taxanes and novel agents--more or less.

Barrett-Lee P, Ellis P, Bliss J; TACT Trial Management Group. Taxotere as Adjuvant Chemotherapy Trial. Barrett-Lee P, et al. Clin Oncol (R Coll Radiol). 2002 Aug;14(4):263-6. doi: 10.1053/clon.2002.0089. Clin Oncol (R Coll Radiol). 2002. PMID: 12206635 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

302 results

Search Page